Mcconnell Dowell Corporation (MDC.AX)
CHAIKIN MONEY FLOW
Trading: BUY @ $0.4
Signal Strength: STRONG
Mcconnell Dowell Corporation (ASX:MDC) current price has highlighted recent buying pressure and the start of a bullish trading conditions. Currently, the CMF is 0.03. During the quarter, the highest CMF value was 0.03 occurring on the Feb 15 2019.
A bullish crossover has been confirmed due the last trading session with is a strong indication of a diretional change. This indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Developed by Marc Chaikin, Chaikin Money Flow measures the amount of Money Flow Volume over a specific period. Money Flow Volume forms the basis for the Accumulation Distribution Line. Instead of a cumulative total of Money Flow Volume, Chaikin Money Flow simply sums Money Flow Volume for a specific look-back period, typically 20 or 21 days. The resulting indicator fluctuates above/below the zero line just like an oscillator. Chartists weigh the balance of buying or selling pressure with the absolute level of Chaikin Money Flow. Chartists can also look for crosses above or below the zero line to identify changes on money flow.
Calculation: Chaikin Money Flow (20):
1) Money Flow Multiplier = [(Close - Low) - (High - Close)] / (High - Low);
2) Money Flow Volume = Money Flow Multiplier x Volume for the Period;
3) 20-period CMF = 20-period Sum of Money Flow Volume / 20 period Sum of Volume;
PROFILE: Mcconnell Dowell Corporation (MDC.AX)
Stock Exchange: ASX
Company: Mcconnell Dowell Corporation
Ticker Codes: | MDC.AX | ASX:MDC |
Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. The company has a strategic alliance with Heritage Brands Limited to develop and market its products for the pharmacy retail channel. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.
Chaikin Money FlowDownload
|BGA Bega Cheese||5.09||7.4||1,107,047||-0.13||BEARISH|
|NEC Nine Entertainment||1.49||7.2||17,312,234||-0.41||BEARISH|
|FDV Frontier Digital Ventures||0.51||6.3||308,940||-0.22||BEARISH|
|ONE Oneview Healthcare||0.48||5.6||567||-0.1||BEARISH|